Park, Yune-Jung https://orcid.org/0000-0002-7346-0820
Gherghe, Ana Maria
van der Heijde, Desirée https://orcid.org/0000-0002-5781-158X
Clinical trials referenced in this document:
Documents that mention this clinical trial
Radiographic progression in clinical trials in rheumatoid arthritis: a systemic literature review of trials performed by industry
https://doi.org/10.1136/rmdopen-2020-001277
Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naïve patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study
https://doi.org/10.1136/annrheumdis-2015-209057
Documents that mention this clinical trial
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region
https://doi.org/10.1136/rmdopen-2014-000044
Radiographic progression in clinical trials in rheumatoid arthritis: a systemic literature review of trials performed by industry
https://doi.org/10.1136/rmdopen-2020-001277